These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

797 related items for PubMed ID: 15814718

  • 1. Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies.
    He Y, Lu H, Siddiqui P, Zhou Y, Jiang S.
    J Immunol; 2005 Apr 15; 174(8):4908-15. PubMed ID: 15814718
    [Abstract] [Full Text] [Related]

  • 2. Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.
    He Y, Li J, Li W, Lustigman S, Farzan M, Jiang S.
    J Immunol; 2006 May 15; 176(10):6085-92. PubMed ID: 16670317
    [Abstract] [Full Text] [Related]

  • 3. Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines.
    He Y, Zhu Q, Liu S, Zhou Y, Yang B, Li J, Jiang S.
    Virology; 2005 Mar 30; 334(1):74-82. PubMed ID: 15749124
    [Abstract] [Full Text] [Related]

  • 4. Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine.
    He Y, Li J, Du L, Yan X, Hu G, Zhou Y, Jiang S.
    Vaccine; 2006 Jun 29; 24(26):5498-508. PubMed ID: 16725238
    [Abstract] [Full Text] [Related]

  • 5. A single amino acid substitution (R441A) in the receptor-binding domain of SARS coronavirus spike protein disrupts the antigenic structure and binding activity.
    He Y, Li J, Jiang S.
    Biochem Biophys Res Commun; 2006 May 26; 344(1):106-13. PubMed ID: 16615996
    [Abstract] [Full Text] [Related]

  • 6. Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design.
    He Y, Li J, Heck S, Lustigman S, Jiang S.
    J Virol; 2006 Jun 26; 80(12):5757-67. PubMed ID: 16731915
    [Abstract] [Full Text] [Related]

  • 7. Neutralizing epitopes of the SARS-CoV S-protein cluster independent of repertoire, antigen structure or mAb technology.
    Berry JD, Hay K, Rini JM, Yu M, Wang L, Plummer FA, Corbett CR, Andonov A.
    MAbs; 2010 Jun 26; 2(1):53-66. PubMed ID: 20168090
    [Abstract] [Full Text] [Related]

  • 8. Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.
    Yi CE, Ba L, Zhang L, Ho DD, Chen Z.
    J Virol; 2005 Sep 26; 79(18):11638-46. PubMed ID: 16140741
    [Abstract] [Full Text] [Related]

  • 9. Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus.
    Shih YP, Chen CY, Liu SJ, Chen KH, Lee YM, Chao YC, Chen YM.
    J Virol; 2006 Nov 26; 80(21):10315-24. PubMed ID: 17041212
    [Abstract] [Full Text] [Related]

  • 10. Antibody binding site mapping of SARS-CoV spike protein receptor-binding domain by a combination of yeast surface display and phage peptide library screening.
    Zhang X, Wang J, Wen K, Mou Z, Zou L, Che X, Ni B, Wu Y.
    Viral Immunol; 2009 Dec 26; 22(6):407-15. PubMed ID: 19951177
    [Abstract] [Full Text] [Related]

  • 11. Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.
    Zhang H, Wang G, Li J, Nie Y, Shi X, Lian G, Wang W, Yin X, Zhao Y, Qu X, Ding M, Deng H.
    J Virol; 2004 Jul 26; 78(13):6938-45. PubMed ID: 15194770
    [Abstract] [Full Text] [Related]

  • 12. Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.
    ter Meulen J, van den Brink EN, Poon LL, Marissen WE, Leung CS, Cox F, Cheung CY, Bakker AQ, Bogaards JA, van Deventer E, Preiser W, Doerr HW, Chow VT, de Kruif J, Peiris JS, Goudsmit J.
    PLoS Med; 2006 Jul 26; 3(7):e237. PubMed ID: 16796401
    [Abstract] [Full Text] [Related]

  • 13. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.
    Du L, Zhao G, He Y, Guo Y, Zheng BJ, Jiang S, Zhou Y.
    Vaccine; 2007 Apr 12; 25(15):2832-8. PubMed ID: 17092615
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.
    Zhou T, Wang H, Luo D, Rowe T, Wang Z, Hogan RJ, Qiu S, Bunzel RJ, Huang G, Mishra V, Voss TG, Kimberly R, Luo M.
    J Virol; 2004 Jul 12; 78(13):7217-26. PubMed ID: 15194798
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epitope mapping and biological function analysis of antibodies produced by immunization of mice with an inactivated Chinese isolate of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
    Chou TH, Wang S, Sakhatskyy PV, Mboudjeka I, Lawrence JM, Huang S, Coley S, Yang B, Li J, Zhu Q, Lu S.
    Virology; 2005 Mar 30; 334(1):134-43. PubMed ID: 15749129
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).
    Lai SC, Chong PC, Yeh CT, Liu LS, Jan JT, Chi HY, Liu HW, Chen A, Wang YC.
    J Biomed Sci; 2005 Oct 30; 12(5):711-27. PubMed ID: 16132115
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.